Research Frontiers in CYP19A1 Variants in Aromatase Inhibitor Response Prediction
Study of cytochrome P450 19A1 genetic polymorphisms affecting aromatase enzyme activity and estrogen suppression efficacy in hormone receptor-positive breast cancer patients.